Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.26

+1.2%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Metcalf who wrote (94)	3/23/1999 9:25:00 AM
From: LLCF	Read Replies (2) of 52153

O.K. fresh update to take into account some price changes, notable SNAP, and PGNS... I'm thinking about splitting "REVS" into product earnings vs contract earnings? Any other ideas columns to add? Comp # Sh(mil) $(mil) $/shr Price Cap(mil) %$/Val 98'Exp Revs OSIP 21.4 $22 1.04 3.5 $75 30% 31.0 19.5 BTRN 8.6 $20 2.33 2.25 $19 104% 17.2 8.0 CEPH 28.7 $60 2.09 10 $287 21% 74.6 15.6 CORR 24.4 $50 2.05 8.5 $207 24% 73.2 41.9 TTP 13.1 $14 1.07 4 $52 27% MLNM 34.2 $150 4.38 34 $1,163 13% 139.0 133.7 INCY 29.3 $110 3.75 23 $675 16% 133.0 134.8 MBIO 19.6 $57 2.91 5 $98 58% 18.7 8.1 AXPH 30.0 $75 2.50 4 $120 63% 203.6 47.4 SIBI 9.0 $22 2.44 5 $45 49% annual due out ONXX 11.4 $20 1.75 6 $69 29% 30.6 11.3 LGND 35.0 $41 1.17 9 $315 13% wait for annual GLFD 19.6 $120 6.14 10.5 $205 58% 50.3 12.5 GLIA 10.1 $27 2.62 23 $233 11% 22.0 17.3 NPSP 12.5 $40 3.20 6.5 $81 49% 23.4 3.6 CTII 18.4 $12 0.65 1.5 $28 43% 22.3 8.8 CELG 16.4 $18 1.06 13 $214 8% wait for annual PARS 37.0 $4 0.11 1.25 $46 9% 6.1 1.5 ALKS 24.9 $171 6.87 30 $747 23% 45.9 40.0 MEDX 31.3 $30 0.96 3.5 $110 27% 29.2 6.7 GELX 16.0 $110 6.87 17 $272 40% 41.1 32.7 PGNS 17.2 $65 3.79 12 $206 32% 62.6 61.1 CGPI 8.6 $10 1.17 10 $86 12% 16.0 3.0 NBIX 18.8 $59 3.14 6 $113 52% 28.5 16.0 PCOP 20.2 $52 2.57 9 $182 29% 105.7 92.2 PDLI 18.6 $140 7.53 16 $297 47% 40.0 30.0 VRTX 25.3 $245 9.67 26.5 $672 36% 77.5 44.5 CLTR 17.3 $130 7.52 23.5 $407 32% 40.0 34.0 ABGX 14.1 $55 3.90 15 $212 26% 21.0 3.8 SNAP 10.7 $28 2.64 6.5 $70 41% 15.5 10.0 MOGN 15.0 $17 1.13 7.75 $116 15% 15.1 17.6 SUPG 20.4 $13 0.62 10 $204 6% 19.5 3.0 AVIR 15.7 $80 5.10 20 $314 25% 56.6 1.0 PCYC 12.3 $45 3.66 17.75 $218 21% wait for annual LKST 11.90 26.50 2.23 10 $119 22% 21.0 9.0 *Revs & Exp in Millions ALKS 9 month data,SIBI lawsuit not included,LGND warrants not included. AXPH had 124.888 mill. Aquired R&D expenses. GLFD stock buyback not included,CEPH recent financing not included. DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next